tiprankstipranks

Ken Herrmann Insider Profile

4 Followers
Ken Herrmann, Director at Aktis Oncology, Inc., holds 0.00 shares in Aktis Oncology, Inc. (Ticker: AKTS).
tipranks
Ken Herrmann

Ken Herrmann
Aktis Oncology, Inc. (AKTS)
Director

Ranked #56,639 out of 108,575 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-2.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Ken Herrmann does not currently own shares as a corporate insider.
A breakdown of Ken Herrmann's holdings

Insider Roles

Aktis Oncology, Inc.
(AKTS)
Director
Roles that Ken Herrmann holds in companies

Most Profitable Insider Trade

Stock:
Aktis Oncology, Inc.
(AKTS)
Rating:Informative Sell
Date:Jul 21, 2026 - Today
Return:-1.20%
The most profitable trade made by Ken Herrmann

Ken Herrmann's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Aktis Oncology, Inc.
Jul 21, 2026
Director
Uninformative Buy
2.86K
$0.00
Success Rate for
AKTS
0 out of 2 profitable transactions on
AKTS
0%
Average Return for
AKTS
Average return per transaction on
AKTS
-2.60%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jul 20, 2026
Uninformative Buy
$245.20
3,065
$0.08
Jul 21, 2026
Uninformative Buy
$2.86K
4,856
$0.58
Jul 20, 2026
Informative Sell
$77.24K
3,065
$25.20
-4.00%
Jul 21, 2026
Informative Sell
$119.26K
4,856
$24.56
-1.20%
List of latest transactions for each holding click on a transaction to see Ken Herrmann's performance on stock

Ken Herrmann insider profile FAQ

What is the percentage of profitable transactions made by Ken Herrmann?
The percentage of profitable transactions made by Ken Herrmann is 0%.
    What is the average return per transaction made by Ken Herrmann?
    The average return per transaction made by Ken Herrmann is -2.60%.
      What stocks does Ken Herrmann hold?
      Ken Herrmann holds: AKTS stocks.
        What was Ken Herrmann’s latest transaction?
        Ken Herrmann latest transaction was an Uninformative Buy of $2.86K.
          What was Ken Herrmann's most profitable transaction?
          Ken Herrmann’s most profitable transaction was an Informative Sell of AKTS stock on July 21, 2026. The return on the trade was -1.20%.
            What is Ken Herrmann's role in Aktis Oncology, Inc.?
            Ken Herrmann's role in Aktis Oncology, Inc. is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.